NCT07561658Not yet recruiting
TelePharm PrEP/PEP
Leveraging Telehealth to Optimize PrEP and PEP Delivery at Pharmacies in Kenya
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
In this study, the investigators will evaluate whether introducing a remote nurse to screen, counsel, and guide clients through HIV self-testing (via a telehealth platform) and support interested clients (via SMS) between pharmacy visits increases PrEP/PEP initiations and continuation compared to standard PrEP/PEP delivery by pharmacy providers. The investigators hypothesize that pharmacy PrEP/PEP services delivered with telehealth support will result in better service utilization and implementation outcomes compared to standard delivery and be cost-effective to implement.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1580 (estimated)
- First submitted
- 24 Apr 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 31 Mar 2028
- Lead sponsor
- Fred Hutchinson Cancer Center
- Diseases
- HIV
- NCT number
- NCT07561658
What you commit to
- Study type: Interventional
- Planned participants: 1580
- From 1 Oct 2026 to the primary completion date, 31 Mar 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Currently enrolled in any other HIV vaccine or prevention trial
- Have a condition that would preclude provision of informed consent, make study participation unsafe, complicate interpretation of outcome data, or otherwise interfere with achieving study objectives
Other
- Clients
- Unwilling to provide a phone number at which an RA can reach them for completing surveys and communicate important study-related information
Who the study is looking for
- Pharmacies
- Registered with the Pharmacy and Poisons Board (PPB)
- Must have at least one full-time licensed pharmacist or pharmaceutical technologist on staff
- Must have a private room where HIV testing and PrEP/PEP counseling can occur
- \>3 km from other study pharmacies
- Willing to participate in research activities, including 2-day training for pharmacy providers
- Willing to share pharmacy records with us
- Sells HIVST kits that are WHO certified.
- Pharmacists/remote nurses
- ≥ 18 years old
- Licensed pharmacist, pharmaceutical technologist, or nurse
- Willing to provide PrEP and PEP services, including HIV testing and associated counseling services
- Willing to complete training on PEP/PrEP service delivery at pharmacies, including certification for rapid diagnostic testing
- Able and willing to provide informed consent
- Clients
- ≥ 15 years old
- Interested in being screened for PrEP or PEP
- Meets all criteria to be eligible for pharmacy-delivered PrEP or PEP on the Prescribing Checklist, including being at risk for HIV and not having any medical conditions that might contraindicate PrEP/PEP safety
- Able and willing to provide informed consent
Age in the registry: 15 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kenya Medical Research Institute Coordinator of this site? Confirm its status | Kisumu | Kenya | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.